ADC Therapeutics | 4:持股变动声明-股东 Redmile Group, LLC
ADC Therapeutics | 4:持股变动声明-董事 Azelby Robert
ADC Therapeutics | 4:持股变动声明-董事 BIZZARI JEAN-PIERRE
ADC Therapeutics | 4:持股变动声明-董事 Hug Peter
ADC Therapeutics | 4:持股变动声明-董事 Monges Viviane
ADC Therapeutics | 4:持股变动声明-董事 Pfisterer Thomas
ADC Therapeutics | 4:持股变动声明-董事 Sandor Victor
ADC Therapeutics | 4:持股变动声明-董事 Squarer Ron
ADC Therapeutics | 4:持股变动声明-董事 Azelby Robert
ADC Therapeutics | 4:持股变动声明-董事 BIZZARI JEAN-PIERRE
ADC Therapeutics | 4:持股变动声明-董事 Hug Peter
ADC Therapeutics | 4:持股变动声明-董事 Pfisterer Thomas
ADC Therapeutics | 4:持股变动声明-董事 Sandor Victor
ADC Therapeutics | 4:持股变动声明-董事 Squarer Ron
ADC Therapeutics | 4:持股变动声明-董事 Monges Viviane
ADC Therapeutics | 3:首次持股声明-股东 WILD HANS PETER
ADC Therapeutics | 3:首次持股声明-董事 Pfisterer Thomas
ADC Therapeutics | 4:持股变动声明-股东 Redmile Group, LLC
ADC Therapeutics | 4:持股变动声明-高管 MALLIK AMEET
ADC Therapeutics | SC 13G:超过5%持股股东披露文件-Oaktree Fund Administration, LLC(5.19%),Oaktree Capital Holdings, LLC(5.19%)等
暂无数据
暂无数据